4-(Trifluoromethyl)cyclohexanol, cis/trans, 97.0%, 250mg

3,6-Dimethoxy-2-nitrobenzaldehyde, 95+%, 1g

2-(4-((2-Chlorothiazol-5-yl)methoxy)phenyl)acetonitrile, 95+%, 5g

Tetradecyl Acrylate (stabilized with MEHQ)>95.0%(GC)500mL

1-(BENZYLOXY)-3-FLUORO-2-NITROBENZENE, 95.0%, 5g

1-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-ethylamine hydrochloride, 95.0%, 100mg

(S)-tert-Butyl 2-amino-2-phenylacetate, 95.0%, 10g

(S)-4,4-Difluoropyrrolidine-2-carboxylic acid, 95.0%, 10g

2,5-Dimethyl-thiophene-3-carboxylic acid, 95.0%, 25g

2-Chlorodibenzo[b,f][1,4]oxazepin-11(10H)-one, 95.0%, 50g

N-Boc-Prop-2-ynylamine, 98.00%, 100g

tert-Butyl 4-(4-formylbenzyl)piperazine-1-carboxylate, 97%, 100mg

2-(3,4-Dihydro-2h-1,5-benzodioxepine-7-sulfonamido)propanoic acid, 95%, 100mg